0000873303-12-000005.txt : 20120425 0000873303-12-000005.hdr.sgml : 20120425 20120425171826 ACCESSION NUMBER: 0000873303-12-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120424 FILED AS OF DATE: 20120425 DATE AS OF CHANGE: 20120425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christopher Nishan Garabedian CENTRAL INDEX KEY: 0001492604 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 12780478 MAIL ADDRESS: STREET 1: 333 RIVER STREET STREET 2: #303 CITY: HOBOKEN STATE: NJ ZIP: 07030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 425-354-5038 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY STREET 2: SUITE 101 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 edgardoc.xml PRIMARY DOCUMENT X0305 4 2012-04-24 0 0000873303 AVI BIOPHARMA INC AVII 0001492604 Christopher Nishan Garabedian 3450 MONTE VILLA PARKWAY, SUITE 101 BOTHELL WA 98021 1 1 0 0 President and CEO Common Stock 2012-04-24 4 A 0 81666 0 A 511666 D Stock Option (right to buy) 0.9 2012-04-24 4 A 0 245000 0 A 2022-04-24 Common Stock 245000 245000 D Of the 511,666 shares beneficially owned following the reported transaction, 81,666 relate to restricted stock units granted on the Transaction Date and 430,000 reflect shares of common stock directly beneficially owned by reporting person. This option is exercisable at the rate of 25% of the shares on April 24, 2013 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on April 24, 2016. By: Bryan King For: Christopher Nishsan Garabedian 2012-04-25